Open AccessPreclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules
Author(s) -
Danielle M. Burgenske,
Surabhi Talele,
Jenny L. Pokorny,
Ann C. Mladek,
Katrina K. Bakken,
Brett L. Carlson,
Mark A. Schroeder,
Lihong He,
Zeng Hu,
Gautham Gampa,
Matthew Kosel,
Paul A. Decker,
Gaspar J. Kitange,
Anne SchmittHoffmann,
Felix Bachmann,
Rachael A. Vaubel,
Jeanette E. EckelPassow,
Caterina Giannini,
Paul M.J. McSheehy,
Heidi A. Lane,
William F. Elmquist,
Jann N. Sarkaria
Publication year - 2021
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noab162
Subject(s) - temozolomide , medicine , oncology , radiation therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom